Researchers evaluated the association between Assessment of Spondyloarthritis International Society Health Index (ASAS-HI) and disease activity and burden in patients with spondyloarthritis.
Researchers assessed data on intestinal permeability in patients with spondyloarthritis and rheumatoid arthritis and the effects of nonsteroidal anti-inflammatory drugs on intestinal permeability.
Higher body mass index (BMI) seems to be associated with an increased risk for developing psoriasis.
Individuals with co-occurrence of vitiligo and psoriasis have an increased risk for autoimmunity and family history of psoriasis.
Using the CORRONA (now CorEvitas) PsA/SpA Registry, study authors compared the characteristics of patients with axial psoriatic arthritis and axial spondyloarthritis.
Researchers assessed the efficacy and safety of tofacitinib in adult patients with active ankylosing spondylitis.
The primary objective of the study was to compare the clinical characteristics of patients with spondyloarthritis with and without root joint disease.
Greater skin clearance among psoriasis patients is associated with greater improvements in quality of life.
In light of Arthritis Awareness Month, Frédéric Lavie, MD, PhD, describes the current landscape and the future of psoriatic arthritis treatment for patients.
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.